Case Studies

A precision medicine company faced payer resistance for their innovative targeted therapy in a rare hematologic indication. Complex mechanism of action and limited real-world evidence created access barriers despite breakthrough clinical data.

We deployed integrated value communication expertise, combining deep therapeutic knowledge with strategic market access intelligence to create a comprehensive communication ecosystem.

Value dossier accepted across key markets

A global pharmaceutical leader developing next-generation therapy for rare bleeding disorders needed comprehensive regulatory and HTA landscape intelligence to optimize Phase 3 design and prepare for joint scientific advice.

We integrated regulatory and HTA intelligence capabilities, combining systematic landscape analysis with strategic stakeholder engagement planning to deliver actionable development insights.

Comprehensive regulatory and HTA landscape assessment

A leading patient advocacy organization identified critical knowledge gaps in post-transplant care for inherited metabolic disorders.

We committed to conducting a comprehensive pro-bono systematic literature review, delivering methodologically rigorous research to advance patient care understanding and clinical practice.

First systematic review of acquired metabolic conditions post-transplant

A leading medical device company needed stronger medical communications for its spine and neurosurgery portfolio. Gaps included: no clear publication process, limited writing capacity, and uneven use of clinical evidence.

We provided an integrated solution spanning medical communications, clinical development, and market access. 

End-to-end publication and communication framework in place